Diabetes
Conditions
Interventions
Gold Standard:1.New Technology in Intelligent Diagnosis
This study uses centralized image reading, where specialists from tertiary hospitals interpret images of diabetes complications based on the "Ex
(2) Diabetic Nephropathy: Based on the "Chinese Guidelines for the Prevention and Treatment of Diabetic Kidney Disease (2021 Edition)"
(3) Carotid Atherosclerosis: Assessed using carotid ultrasound to measure intima-media thickness and plaques, among other indicators
(4) Lower Limb Vascular Disease: Assessed using lower limb vascular ultrasound to examine blood vessels and plaques
(5) Diabetes-Related Cognitive Impairment: Assessed using the Montreal Cognitive Assessment (MoCA) to evaluate cognitive function in diabetic patients.
Index test:Novel Technology for Intelligent Screening, Diagnosis, and Early Warning of Diabetic Complications
Sponsors
Tianjin Medical University Chu Hsien-I Memorial Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. New Technology for Intelligent Diagnosis: (1) Patients diagnosed with type 1 or type 2 diabetes; (2) Age >= 18 years; (3) Participants fully understand the purpose, nature, and methods of the study, voluntarily agree to participate, and sign the informed consent form; (4) Availability of imaging data for chronic diabetic complications or comorbidities. 2.New Technology for Intelligent Screening and Early Warning: (1) Patients diagnosed with type 1 or type 2 diabetes; (2) Age >= 18 years; (3) Participants fully understand the purpose, nature, and methods of the study, voluntarily agree to participate, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. New Intelligent Diagnostic Technologies: (1) Individuals with severe mental illness or speech disorders; (2) Patients with malignant tumors; (3) Pregnant or breastfeeding women; (4) Suspected active infections (such as active tuberculosis, pneumonia, etc.); (5) Individuals with poor image quality. 2. New Technologies for Intelligent Screening and Early Warning (1) Individuals with severe mental illness or language disorders; (2) Patients with malignant tumors; (3) Pregnant or breastfeeding women; (4) Suspected active infections (such as active tuberculosis, pneumonia, etc.); (5) Severe liver or kidney dysfunction (alanine aminotransferase and/or aspartate aminotransferase > 3 times the upper limit of normal; estimated eGFR < 15 mL/min/1.73m^2).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Area Under the Curve, AUC;Positive Predictive Value (PPV);Negative Predictive Value (NPV); | — |
Countries
China
Contacts
Public ContactChen Liming
Tianjin Medical University Chu Hsien-I Memorial Hospital
Outcome results
None listed